Literature DB >> 23584460

Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.

Seung Pil Jung1, Minkuk Kim, Jun-Ho Choe, Jee Soo Kim, Seok Jin Nam, Jung-Han Kim.   

Abstract

BACKGROUND: Macroscopic extrathyroidal extension (ETE) is a poor prognostic factor in papillary thyroid carcinoma (PTC). However, intraoperative inspection for ETE is often inaccurate and could lead the surgeon to misconstrue simple adhesion as gross ETE. Such confusion could result in more aggressive treatment than necessary. In the present study we investigated the frequency and clinical implication of simple adhesions.
METHODS: We identified 858 patients who underwent total thyroidectomy for papillary thyroid carcinoma (PTC). Clinicopathologic features, prognosis, and stimulated serum thyroglobulin (Tg) levels were compared between four groups divided according to degree of ETE: no ETE (n = 335), simple adhesion (n = 16), microscopic ETE (n = 378), and macroscopic ETE (n = 129).
RESULTS: In the total of 145 cases, which were recognized as gross ETE under intraoperative inspection, 16 cases (11.0 %) were diagnosed as cancer confined to the thyroid without ETE by definite histology. The simple adhesion group showed no statistical differences in postoperative stimulated Tg levels from the no ETE and microscopic ETE groups (p > 0.05). In contrast, the distribution of postoperative Tg levels in the macroscopic ETE group was significantly higher than in the other groups (p < 0.001). During the 54-month median follow-up period, the macroscopic ETE and microscopic ETE groups showed poorer relapse-free survival than the no ETE and simple adhesion groups (p < 0.05).
CONCLUSIONS: The findings of the present study indicate that the discrepancy between intraoperative inspection and definite histology is not negligible when dense adhesions are present. When no tumor is found, the patient with inflammatory or fibrotic adhesions has a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23584460     DOI: 10.1007/s00268-013-2034-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

Review 1.  Histological alterations following thyroid fine needle biopsy: a systematic review.

Authors:  Stergios A Polyzos; Kalliopi Patsiaoura; Konstantia Zachou
Journal:  Diagn Cytopathol       Date:  2009-06       Impact factor: 1.582

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 3.  Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.

Authors:  J D Lin; M J Liou; T C Chao; H F Weng; Y S Ho
Journal:  Endocr Relat Cancer       Date:  1999-03       Impact factor: 5.678

4.  Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?

Authors:  Hee Jung Moon; Eun-Kyung Kim; Woong Youn Chung; Jung Hyun Yoon; Jin Young Kwak
Journal:  Ann Surg Oncol       Date:  2011-01-26       Impact factor: 5.344

Review 5.  Role of extended resection in the initial treatment of locally advanced colorectal carcinoma.

Authors:  M J Lopez; W W Monafo
Journal:  Surgery       Date:  1993-04       Impact factor: 3.982

6.  Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

Authors:  F Pacini; F Lippi; N Formica; R Elisei; S Anelli; C Ceccarelli; A Pinchera
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

7.  Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies?

Authors:  E G Black; R Hoffenberg
Journal:  Clin Endocrinol (Oxf)       Date:  1983-11       Impact factor: 3.478

8.  Histologic alterations in the thyroid gland after fine-needle aspiration.

Authors:  C Ersöz; L Soylu; E U Erkoçak; T Tetiker; D Gümürdülü
Journal:  Diagn Cytopathol       Date:  1997-03       Impact factor: 1.582

Review 9.  Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.

Authors:  C A Spencer; C C Wang
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

10.  Differentiated carcinoma of the thyroid with extrathyroidal extension.

Authors:  P E Andersen; J Kinsella; T R Loree; A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565

View more
  9 in total

1.  Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.

Authors:  D Ahn; J H Sohn; J H Jeon; J Y Jeong
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

2.  Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor.

Authors:  M G Castagna; R Forleo; F Maino; N Fralassi; F Barbato; P Palmitesta; T Pilli; M Capezzone; L Brilli; C Ciuoli; S Cantara; C Formichi; F Pacini
Journal:  J Endocrinol Invest       Date:  2018-02-22       Impact factor: 4.256

3.  The influence of nodule size on the aggressiveness of thyroid carcinoma varies with patient's age.

Authors:  Chaoyang Meng; Wenlong Wang; Yuezhong Zhang; Xinying Li
Journal:  Gland Surg       Date:  2021-03

4.  Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.

Authors:  Dao-Zhe Lin; Ning Qu; Rong-Liang Shi; Zhong-Wu Lu; Qing-Hai Ji; Wei-Li Wu
Journal:  Onco Targets Ther       Date:  2016-08-24       Impact factor: 4.147

Review 5.  Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma.

Authors:  De-Tao Yin; Kun Yu; Run-Qing Lu; Xianghua Li; Jianhui Xu; Mengyuan Lei
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  Sonographic Assessment of the Extent of Extrathyroidal Extension in Thyroid Cancer.

Authors:  Sae Rom Chung; Jung Hwan Baek; Young Jun Choi; Tae Yon Sung; Dong Eun Song; Tae Yong Kim; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2020-07-17       Impact factor: 3.500

7.  Association Between the Presence of Female-Specific Tumors and Aggressive Clinicopathological Features in Papillary Thyroid Cancer: A Retrospective Analysis of 9,822 Cases.

Authors:  Jiao Zhang; Le Zhou; Gianlorenzo Dionigi; Daqi Zhang; Lina Zhao; Nan Liang; Gaofeng Xue; Hui Sun
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

8.  Preoperative Factors Associated with Extrathyroidal Extension in Papillary Thyroid Cancer.

Authors:  Chi-Yu Kuo; Po-Sheng Yang; Ming-Nan Chien; Shih-Ping Cheng
Journal:  Eur Thyroid J       Date:  2020-04-14

9.  Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.

Authors:  Shuai Xue; Li Zhang; Renzhu Pang; Peisong Wang; Meishan Jin; Liang Guo; Yuhua Zhou; Bingfei Dong; Guang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.